CV: Peep Veski

Teenistuskäik

Töökohad ja ametid

1980-1981 - TÜ farmaatsia instituudi assistent

1981-1986 - TÜ farmaatsia instituudi vanemõpetaja

1986-1998 - TÜ farmaatsia instituudi dotsent

1998 - - TÜ farmatseutilise tehnoloogia ja biofarmaatsia professor, farmaatsia instituudi juhataja

01.02.2008–01.10.2014

Tartu Ülikool, Arstiteaduskond, Farmaatsia instituut, ravimite tehnoloogia ja biofarmaatsia professor (1,00)

01.02.2003–31.01.2008

Tartu Ülikool, Arstiteaduskond, Farmaatsia instituut, ravimite tehnoloogia ja biofarmaatsia professor (1,00)

Haridustee

Semmelweisi Ülikool (Budapest) - lõpetanud 1975.aastal, proviisor

Teadusorganisatsiooniline ja -administratiivne tegevus

2007−...

2nd BBBB (Balaton-Balti-Bled-Bosporus) konverents, org. komitee esimees

2006−...

EAFP (European Association of Faculties of Pharmacy) konverents, org. komitee esimees

Euroopa Farmakopöa Ekspertkomisjoni G12 (Galenical Products) liige

TÜ Arstiteaduskonna prodekaan 01.02.1998-15.03.2002

EUFEPS (European Federation for Pharmaceutical Sciences) mitme töögrupi liige

EMEA ekspert

EV Sotsiaalministeeriumi juures asuva farmaatsiaterminoloogia komisjoni liige

Ajakirjade "Ars Pharmaceutica" ja Euro Pharma Faculties News" toimetuskolleegiumi liige

2000−2009

EAFP (European Association of Faculties of Pharmacy) juhatuse liige 2000-2009

Kvalifikatsioon

Teaduskraadid

Peep Veski, doktorikraad, 1994, (juh) Martti Marvola, Use of Hard Gelatin Capsules and Sodium Alginates in Peroral Prolonged-release Formulations, Helsingi Ülikool.

Peep Veski, doktorikraad, 1980, (juh) Verzar-Petri Gizella, Kannabinoidok elöfordulasa es megoszlasa a kenderfajtakban, Ungari Teaduste Akadeemia.

Teaduspreemiad ja tunnustused

2013, Peep Veski, Semmelweisi Ülikooli audoktor

2010, Peep Veski, TÜ väike medal

2009, Peep Veski, EAFS tunnustus

2008, Peep Veski, Euroopa Farmaatsiatöötuse Assotsiatsioonide Föderatsiooni auhind

2006, Peep Veski, Ungari Farmaatsiaseltsi auliige

2006, Peep Veski, Complutense Ülikooli (Madrid) medal

2003, Peep Veski, Hispaania Kuningliku Farmaatsia-akadeemia korrespondentliige

Teadustöö põhisuunad

ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.3. Farmaatsia

ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.3. Farmaatsia; TÄPSUSTUS: Tahkete ravimvormide disainimine, raviaine in vitro vabanemine, in vivo-in vitro korrelatsioonid, modifitseeritud toimekestvusega ravimpreparaatide disainimine, ravimpreparaatide biofarmatseutiline kvaliteet, tahke aine füüsikalised karakteristikud, abiainete funktsionaalsus, kronobiofarmatseutilised uuringud

Lisainfo

PhD (Bioloogia)
Ungari Teaduste Akadeemia, 1980
PhD (Farmaatsia)
Helsingi Ülikool, 1994

Jooksvad projektid

IUT34-18
"Multifunktsionaalsete nanomeditsiiniliste süsteemide väljatöötamine ja kvaliteedi hindamine. (1.01.2015−31.12.2020)", Jyrki Tapio Heinämäki, Tartu Ülikool, Meditsiiniteaduste valdkond, farmaatsia instituut.

Lõppenud projektid

ETF7980
"Tahke raviaine füsikokeemilised omadused ja nende modifitseerimise võimalused (1.09.2010−31.08.2016)", Karin Kogermann, Tartu Ülikool, Arstiteaduskond.

Juhendamisel väitekirjad

Kersti Teder, doktorant, (juh) Andres Meos; Peep Veski; Irja Uiboleht; Juri Karjagin, Bioavailability of oral N-acetylcysteine in different intensive care unit patient groups (Suukaudselt manustatud N-atsetüültsüsteiini biosaadavus erineva hospitaliseerimisnäidustusega intensiivravi osakonna patsientidel), Tartu Ülikool, Meditsiiniteaduste valdkond, farmaatsia instituut.

Juhendatud väitekirjad

Publikatsioonid

Klass

Aasta

Publikatsioon

1.1.

2014

Paaver, Urve; Tamm, Ingrid; Laidmäe, Ivo; Lust, Andres; Kirsimäe, Kalle; Veski, Peep; Kogermann, Karin; Heinämäki, Jyrki (2014). Soluplus Graft Copolymer: Potential Novel Carrier Polymer in Electrospinning of Nanofibrous Drug Delivery Systems for Wound Therapy. BioMed Research International, 2014, 1−7.10.1155/2014/789765.

1.1.

2014

Paaver, Urve; Heinämäki, Jyrki; Kassamakov, Ivan; Hæggström, Edward; Ylitalo, Tuomo; Nolvi, Anton; Kozlova, Jekaterina; Laidmäe, Ivo; Kogermann, Karin; Veski, Peep (2014). Nanometer depth resolution in 3D topographic analysis of drug-loaded nanofibrous mats without sample preparation. International Journal of Pharmaceutics, 462, 29−37.10.1016/j.ijpharm.2013.12.041.

1.1.

2013

Penkina, A.; Antikainen, O.; Hakola, M.; Vuorinen, S.; Repo, T.; Yliruusi, J.; Veski, P.; Kogermann, K.; Heinämäki, J. (2013). Direct compression of cellulose and lignin isolated by a new catalytic treatment. AAPS PharmSciTech, 14 (3), 1129−1136.10.1208/s12249-013-0002-x.

1.1.

2013

Lust, A; Lakio, S; Vintsevits, J; Kozlova, J; Veski, P; Heinämäki, J; Kogermann, K. (2013). Water-mediated solid-state transformation of a polymorphic drug during aqueous-based drug-layer coating of pellets. International Journal of Pharmaceutics, 456 (1), 41−48.10.1016/j.ijpharm.2013.08.036.

1.1.

2013

Lust, A.; Laidmäe, I; Palo, M.; Meos, A.; Aaltonen, J.; Veski, P.; Heinämäki, J.; Kogermann, K. (2013). Solid-state dependent dissolution and oral bioavailability of piroxicam in rats. European Journal of Pharmaceutical Sciences, 48, 47−54.10.1016/j.ejps.2012.10.005.

1.1.

2013

Kogermann, K.; Penkina, A.; Predbannikova, K.; Jeeger, K.; Veski, P.; Rantanen, J.; Naelapää, K. (2013). Dissolution testing of amorphous solid dispersions. International Journal of Pharmaceutics, 444, 40−46.10.1016/j.ijpharm.2013.01.042.

5.1.

2013

Kogermann, K; Lust, A; Paaver, U; Penkina, A; Kozlova, J; Rantanen, J; Kirsimäe, K; Veski, P; Heinämäki, J; Naelapää, K. (2013). Stability and dissolution behavior of amorphous solid dispersions. 5th BBBB- International Conference; Athens, Greece; 26.09-28.09.2013. x, x.

5.2.

2013

Paaver, U.; Heinämäki, J.; Laidmäe, I.; Lust, A.; Kozlova, J.; Sillaste, E.; Pokrovski, M.; Kirsimäe, K.; Veski, P.; Kogermann, K. (2013). Preparation and characterisation of electrospun nanofibers of piroxicam. The Second Annual NordForsk Researcher Network Meeting: Future Performance Testing of Pharmaceuticals, Jan 31-Feb 1, 2013, Tartu, Estonia. Ed. Paaver, U. University of Tartu, 34.

5.2.

2013

Penkina, A.; Antikainen, O.; Hakola, M.; Vuorinen, S.; Repo, T.; Aaltonen, J.; Yliruusi, J.; Veski, P.; Kogermann, K.; Heinämäki, J. (2013). Direct compression behavior of pretreated softwood lignin and cellulose. The Second Annual NordForsk Researcher Network Meeting: Future Performance Testing of Pharmaceuticals, Jan 31-Feb 1, 2013, Tartu, Estonia. Ed. Paaver, U. University of Tartu, 24.

5.2.

2013

Lust, A.; Lakio, S.; Vintsevits, J.; Kozlova, J.; Veski, P.; Heinämäki, J.; Kogermann, K. (2013). Monitoring of piroxicam solid state changes during aqueous-based drug-layer pellet coating and investigation of it importance. The Second Annual NordForsk Researcher Network Meeting: Future Performance Testing of Pharmaceuticals, Jan 31-Feb 1, 2013, Tartu, Estonia. Ed. Paaver, U. University of Tartu, 16.

5.2.

2013

Penkina, A.; Semjonov, K.; Hakola, M.; Vuorinen, S.; Repo, T.; Yliruusi, J.; Kirsimäe, K.; Kogermann, K.; Veski, P.; Heinämäki, J. (2013). Cryogenic co-grinding of a poorly water-soluble piroxicam with pretreated cellulose and polyvinyl pyrrolidone. The 24th Annual Symposium of Physical Pharmacy, Turku, Finland, February 7, 2013.

5.2.

2013

Penkina, A.; Antikainen, O.; Hakola, M.; Vuorinen, S.; Repo, T.; Yliruusi, J.; Veski, P.; Kogermann, K.; Heinämäki, J. (2013). Compaction behavior of pretreated cellulose and lignin isolated by a new catalytic oxidation and acid precipitation method. The 24th Annual Symposium of Physical Pharmacy, Turku, Finland, February 7, 2013.

5.2.

2013

Volmer D, Shagandina A, Turunen J, Ahonen R, Veski P, Ratassepp T, Heinämäki J. (2013). Counseling practices on personal medical devices in community pharmacies in Estonia. NSPC 2013 Striving for equality in research participation and the implications for care. June 12-13, 2013, Conference Center Wallenberg, Gothenburg, Sweden: NSPC 2013 Striving for equality in research participation and the implications for care. June 12-13, 2013, Conference Center Wallenberg, Gothenburg, Sweden. University of Gothenburg, 51−51.

5.2.

2013

Heinämäki, J.; Shagandina, A.; Turunen, J.; Ahonen, R.; Veski, P.; Ratassepp, T.; Volmer, D. (2013). Dispensing and counseling of personal medical devices at community pharmacies in Estonia. The 73rd FIP World Congress of Pharmacy and Pharmaceutical Sciences, Aug 31- Sep 5, 2013, Dublin, Ireland.

5.2.

2013

Paaver, Urve.; Heinämäki, Jyrki.; Laidmäe, Ivo.; Lust, Andres.; Kozlova, Jekaterina.; Kirsimäe, Kalle.; Veski, Peep.; Kogermann, Karin (2013). Nanofiber-based amorphous solid dispersions of a poorly water-soluble drug and synthetic graft copolymer. The 5th International BBBB Conference; Athens, Greece; 26.09.-28.09.2013.

5.2.

2013

Paaver, Urve; Laidmäe, Ivo; Santos, Hélder A.; Yliruusi, Jouko;, Veski, Peep; Kogermann, Karin; Heinämäki, Jyrki (2013). Electrospun nanofibers as a novel delivery system for a poorly water-soluble β-sitosterol. The 5th International BBBB Conference 26.09.-28.09.2013 Athens, Greece.

5.2.

2013

Paaver, Urve; Heinämäki, Jyrki; Kassamakov, Ivan; Hæggström, Edward; Ylitalo, Tuomo; Nolvi, Anton; Kozlova, Jekaterina; Laidmäe, Ivo; Kogermann, Karin; Veski, Peep (2013). Topographic analysis of electrospun drug-loaded nanofibrous mats without sample preparation. The 5th International BBBB Conference 26.09.-28.09.2013 Athens, Greece.

5.2.

2013

Penkina, A.; Semjonov, K.; Hakola, M.; Vuorinen, S.; Repo, T.; Yliruusi, J.; Kirsimäe, K.; Kogermann, K.; Veski, P.; Heinämäki, J. (2013). Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers. In: .TÜ Arstiteaduskonna Teaduskonverents, Tartu, Estonia, October 10, 2013. Oral presentation.

5.2.

2013

Penkina, A.; Semjonov, K.; Hakola, M.; Vuorinen, S.; Repo, T.; Yliruusi, J.; Kirsimäe, K.; Kogermann, K.; Veski, P.; Heinämäki, J. (2013). Amorphous solid dispersions prepared by a cryogenic co-grinding of a poorly water-soluble piroxicam and carrier polymers. In: .The 5th International BBBB Conference, Athens, Greece, 26-28 September, 2013.

5.2.

2013

Tamm, Ingrid; Heinämäki, Jyrki; Laidmäe, Ivo; Lust, Andres; Kozlova, Jekaterina; Kirsimäe, Kalle; Veski, Peep; Kogermann, Karin; Paaver, Urve (2013). Application of a new synthetic graft copolymer Soluplus in preparing electrospun nanofibers for poorly water-soluble drug. Eesti Arst, 91: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2013, Tartu, 10.-11. 10.2013. Tartu, 13−13. (92 (Lisa 2)).

5.2.

2013

Paaver, Urve; Laidmäe, Ivo; Santos, Hélder A.; Yliruusi, Jouko; Veski, Peep; Kogermann, Karin; Heinämäki, Jyrki (2013). Development of novel nanofibrous system for poorly water-soluble beta-sitosterol. Eesti Arst, 91: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2013, Tartu, 10.-11. 10.2013. Tartu, 43−43. (92 (Lisa 2)).

5.2.

2013

Paaver, Urve; Heinämäki, Jyrki; Kassamakov, Ivan; Ylitalo, Tuomo; Hæggström, Edward; Santos, Hélder A.; Yliruusi, Jouko; Laidmäe, Ivo; Veski, Peep; Kogermann, Karin (2013). In-situ monitoring of drug release from pharmaceutical drug-loaded nanofibers. Eesti Arst, 91: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2013, Tartu, 10.-11. 10.2013. Tartu, 43−43. (92 (Lisa 2)).

5.2.

2013

Laidmäe, Ivo; Salmi, Ari; Rauhala, Timo; Yliruusi, Jouko; Uibo, Raivo; Kogermann, Karin; Veski, Peep; Heinämäki, Jyrki; Hæggström, Edward. (2013). Laserultrasonic electrospinning to prepare non-woven nanomedicines. Eesti Arst, 92 (Lisa 2): Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2013. 48.

5.2.

2013

Paaver, U.; Heinämäki, J.; Kassamakov, I.; Hæggström, E.; Ylitalo, T.; Nolvi, A.; Kozlova, J.; Laidmäe, I.; Kogermann, K.; Veski, P. (2013). Topographic analysis of drug-loaded electrospun nanofibrous mats without sample preparation. Proceedings 5th BBBB International Conference – 26-28 September 2013, Athens, Greece. 21−22.

1.1.

2012

Penkina, A.; Hakola, M.; Paaver, U.; Vuorinen, S.; Kirsimäe, K.; Kogermann, K.; Veski, P.; Yliruusi, J.; Repo, T.; Heinämäki, J. (2012). Solid-state properties of softwood lignin and cellulose isolated by a new acid precipitation method. International Journal of Biological Macromolecules, 51 (5), 939−945.dx.doi.org/10.1016/j.ijbiomac.2012.07.024.

1.1.

2012

Naelapää, Kaisa; Boetker, Johan Peter; Veski, Peep; Rantanen, Jukka; Rades, Thomas; Kogermann, Karin (2012). Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling. International Journal of Pharmaceutics, 249, 69−77.10.1016/j.ijpharm.2012.03.008.

1.1.

2012

Paaver, U.; Lust, A.; Mirza, S.; Rantanen, J.; Veski, P.; Heinämäki, J.; Kogermann, K. (2012). Insight into the solubility and dissolution behavior of piroxicam anhydrate and monohydrate forms. International Journal of Pharmaceutics, 431, 111−119.10.1016/j.ijpharm.2012.04.042.

1.3.

2012

Hinrikus, Toivo; Raal, Ain; Veski, Peep (2012). Tartu ülikooli farmaatsia instituut 170. Eesti Arst, 395−397.

5.2.

2012

Penkina, A.; Hakola, M.; Paaver, U.; Vuorinen, S.; Kogermann, K.; Veski, P.; Yliruusi, J.; Repo, T.; Heinämäki, J. (2012). Thermal properties of catalytic pretreated softwood lignin and lignocellulose. The XXIII Symposium of the Finnish Society of Physical Pharmacy; Espoo, Finland; February 9, 2012.

5.2.

2012

Paaver, U.; Heinämäki, J.; Laidmäe, I.; Kassamakov, I.; Haeggström, E.; Heikkinen, V.; Ylitalo, T.; Nolvi, A.; Kozlova, J.; Veski, P.; Kogermann, K. (2012). Scanning white light interferometer to investigate dimensions and surface morphology of pharmaceutical nanofibers. The XXIII Symposium of the Finnish Society of Physical Pharmacy; Espoo, Finland; February 9, 2012.

5.2.

2012

Lust, A.; Lakio, S.; Vintsevits, J.; Veski, P.; Heinämäki, J.; Kogermann, K. (2012). Water-mediated solid-state transitions of piroxicam in aqueous-based drug-layer coating of pellets. The XXIII Symposium of the Finnish Society of Physical Pharmacy; Espoo, Finland; February 9, 2012.

5.2.

2012

Paaver, U.; Laidmäe, I.; Kozlova, J.; Kirsimäe, K.; Veski, P.; Heinämäki, J.; Kogermann, K. (2012). Investigation of solid-state properties of piroxicam loaded to hydroxypropyl methylcellulose nanofibers. 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; Istanbul, Turkey; March 19-22, 2012.

5.2.

2012

Lust, A.; Lakio, S.; Kozlova, J.; Vintsevits, J.; Veski, P.; Heinämäki, J.; Kogermann, K. (2012). Solid-state transformations of piroxicam during aqueous-based drug-layer coating of pellets. 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; Istanbul, Turkey; March 19-22, 2012.

5.2.

2012

Penkina, A.; Hakola, M.; Paaver, U.; Vuorinen, S.; Kirsimäe, K.; Kogermann, K.; Veski, P.; Yliruusi, J.; Repo, T.; Heinämäki, J. (2012). Solid-state characterisation of catalytic pretreated softwood lignin and lignocellulose intended for pharmaceutical excipients. 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; Istanbul, Turkey; March 19-22, 2012.

5.2.

2012

Penkina, A.; Hakola, M.; Paaver, U.; Vuorinen, S.; Kirsimäe, K.; Kogermann, K.; Veski, P.; Yliruusi, J.; Repo, T.; Heinämäki, J. (2012). Solid-state properties and direct compression behavior of catalytically pretreated softwood lignin and cellulose. Farmaatsia 170, Tartu, Estonia, October 12, 2012.

5.2.

2012

Penkina, A.; Hakola, M.; Paaver, U.; Vuorinen, S.; Kirsimäe, K.; Kogermann, K.; Veski, P.; Yliruusi, J.; Repo, T.; Heinämäki, J. (2012). Evaluation of lignocelluloses and lignin as a potential future excipients in pharmaceutical solid dosage manufacturing. The 1st Annual Meeting of Nordforsk Nordic-Baltic Researcher Network, Helsinki, Finland, February 8, 2012.

5.2.

2012

Lust, A.; Sinkova, J.; Heinämäki, J.; Veski, P.; Aaltonen, J.; Kogermann, K. (2012). Intrinsic dissolution rate and water-mediated phase transformations of piroxicam solid-state forms. The 9th Central European Symposium on Pharmaceutical Technology with focus on Nanopharmaceuticals and Nanomedicine (CESPT 2012). 194.

5.2.

2012

Penkina, A.; Antikainen, O.; Hakola, M.; Vuorinen, S.; Kogermann, K.; Veski, P.; Yliruusi, J.; Repo, T.; Heinämäki, J. (2012). Direct compression of softwood lignin and cellulose isolated by a new catalytic pretreatment method. The 9th Central European Symposium on Pharmaceutical Technology with focus on Nanopharmaceuticals and Nanomedicine (CESPT 2012). 177.

5.2.

2012

Paaver, Urve; Heinämäki, Jyrki; Pokrovski, Marili; Laidmäe, Ivo; Kirsimäe, Kalle; Kozlova, Jekaterina; Veski, Peep; Kogermann, Karin (2012). Preparation and characterisation of electrospun polydextrose nanofibers loaded with piroxicam. Book of Abstracts of the 9th Central European Symposium on Pharmaceutical Technology Nanopharmaceuticals and Nanomedicine: the 9th Central European Symposium on Pharmaceutical Technology Nanopharmaceuticals and Nanomedicine, September 20-22, 2012 Dubrovnik, Croatia. Ed. Lovric, Jasmina; Pepic, Ivan; Filipovic-Grcic, Jelena; Mrhar, Aleš. Croatia: Printera Gruppa d.o.o, 115−115.

5.2.

2012

Paaver, Urve; Heinämäki, Jyrki; Laidmäe, Ivo; Kassamakov, Ivan; Haeggström, Edward; Heikkinen, Ville; Ylitalo, Tuomo; Nolvi, Anton; Kozlova, Jekaterina; Veski, Peep; Kogermann, Karin (2012). Topographic analysis of electrospun nanofibers by means of scanning white light interferometer. Book of Abstracts of the 9th Central European Symposium on Pharmaceutical Technology Nanopharmaceuticals and Nanomedicine: the 9th Central European Symposium on Pharmaceutical Technology Nanopharmaceuticals and Nanomedicine, September 20-22, 2012 Dubrovnik, Croatia. Ed. Lovric, Jasmina; Pepic, Ivan; Filipovic-Grcic, Jelena; Mrhar, Aleš. Croatia: Printera Gruppa d.o.o, 113−113.

5.2.

2012

Penkina, Anna; Antikainen, Osmo; Hakola, Maija; Vuorinen, Sirpa; Repo, Timo; Yliruusi, Jouko; Veski, Peep; Kogermann, Karin; Heinämäki, Jyrki (2012). Direct compression behavior of pretreated softwood lignin and cellulose. Eesti Arst, 91 (Lisa 1): Arstiteaduskonna aastapäeva konverents, 2012. 13.

5.2.

2012

Lust, Andres; Sinkova, Julia; Heinämäki, Jyrki; Veski, Peep; Aaltonen, Jaakko; Kogermann, Karin (2012). Piroksikaami tahke aine vormide sisemise lahustumiskiiruse määramine ja nende võimalikud muutused. Eesti Arst, 91 (Lisa 1): Arstiteaduskonna aastapäeva konverents, 2012. 22.

5.2.

2012

Penkina, Anna; Parajuli, Anirudra; Antikainen, Osmo; Aaltonen, Jaakko; Hakola, Maija; Vuorinen, Sirpa; Repo, Timo; Yliruusi, Jouko; Veski, Peep; Kogermann, Karin; Heinämäki, Jyrki (2012). Influence of wood lignin on mechanical stress-strain and solid-state properties of externally plasticized hydroxypropyl methylcellulose films. Eesti Arst, 91 (Lisa 1): Arstiteaduskonna aastapäeva konverents, 2012. 24.

5.2.

2012

Paaver, Urve; Heinämäki, Jyrki; Pokrovski, Marili; Laidmäe, Ivo; Kirsimäe, Kalle; Kozlova, Jekaterina; Veski, Peep; Kogermann, Karin (2012). Formulation and evaluation of electrospun polydextrose nanofibers loaded with piroxicam. Eesti Arst, 91 (Lisa 1): Arstiteaduskonna aastapäeva konverents, 2012. 46.

5.2.

2012

Paaver, Urve; Heinämäki, Jyrki; Laidmäe, Ivo; Kassamakov, Ivan; Hęggström, Edward; Heikkinen, Ville; Ylitalo, Tuomo; Nolvi, Anton; Kozlova, Jekaterina; Veski, Peep; Kogermann, Karin (2012). Scanning white light interferometer – a novel non-contact method for geometry and surface characterization of pharmaceutical electrospun nanofibers. Eesti Arst, 91 (Lisa 1): Arstiteaduskonna aastapäeva konverents, 2012. 46.

5.2.

2012

Kogermann, Karin; Veski, Peep; Rantanen, Jukka; Naelapää, Kaisa (2012). Dissolution Behavior of Amorphous Material is Influenced by Molecular Weight of the Stabilizing Polymer. The 2012 AAPS Annual Meeting and Exposition, Chicago, IL, USA, October 14-18, 2012..

5.2.

2012

Kogermann, Karin; Penkina, Anna; Veski, Peep; Rantanen, Jukka; Naelapää, Kaisa (2012). Complex dissolution behaviour of co-milled amorphous formulations. The 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; Istanbul, Turkey; March 19-22, 2012.

5.2.

2012

Shagandina, A.; Heinämäki, J.; Turunen, J.; Ahonen, R.; Veski, P.; Volmer, D. (2012). Counseling practices on personal medical devices in community pharmacies in Estonia. Eesti Arst, 91, 37−37.

1.1.

2011

Kogermann, K.; Veski, P.; Rantanen, J.; Naelapää, K. (2011). X-ray powder diffractometry in combination with principal component analysis – A tool for monitoring solid state changes. European Journal of Pharmaceutical Sciences, 43, 278−289.10.1016/j.ejps.2011.05.001.

1.1.

2011

Volmer, D; Lilja, J; Hamilton, D; Bell, JS; Veski, P. (2011). Self-reported competence of Estonian community pharmacists in relation to herbal products: findings from a health-system in transition. Phytotherapy Research, 25 (3), 381−386.

1.1.

2011

5.1.

2011

Laidmäe, I.; Veski, P.; Uibo, R. (2011). Low immunogenicity of salmon fibrin glue. European Journal of Pharmaceutical Sciences, 44: 4th BBBB-Bled International Conference on Pharmaceutical Sciences - New Trends in Drug Discovery, Delivery Systems and Laboratory Diagnostics; Bled, SLOVENIA; SEP 29-OCT 01, 2011.. Elsevier Science BV, 25−26. (Supplement: 1).

5.2.

2011

Palo, M.; Lust, A.; Veski, P.; Kogermann, K. (2011). Abiainete ja amorfse vormi mõju piroksikaami lahustumiskiirusele. Eesti Arst, 90: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2011. 35. (Lisa 1).

5.2.

2011

Ruina, N.; Lust, A.; Veski, P.; Kogermann, K. (2011). Tahke aine muutuste jälgimine kasutades Raman spektroskoopiat. Eesti Arst, 90: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2011. 33. (Lisa 1).

5.2.

2011

Penkina, Anna; Naelapää, Kaisa; Rantanen, Jukka; Veski, Peep; Heinämäki, Jyrki; Kogermann, Karin (2011). Preparation of amorphous piroxicam by co-milling approach. Eesti Arst, 90: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskonverents 2011, Tartu. 23. (Lisa 1).

5.2.

2011

Heinämäki, J.; Hakola, M.; Paaver, U.; Vuorinen, S.; Kirsimäe, K.; Kogermann, K.; Antikainen, O.; Veski, P.; Yliruusi, J.; Repo, T. (2011). Lignin and lignocelluloses- potential future excipients in pharmaceutical solid dosage manufacturing. European Journal of Pharmaceutical Sciences, 44: 4th BBBB- Bled International Conference on Pharmaceutical Sciences, 29.09-01.10.2011, Bled, Slovenia. , 2011, (Vol.44; Supplement 1), p.90-91.. x, 90−91. (1).

5.2.

2011

Kogermann, K., Veski, P., Rantanen, J., Naelapää, K. (2011). Amorphous formulation development- advantages and drawbacks. 44: 4th BBBB- Bled International Conference on Pharmaceutical Sciences, 29.09-01.10.2011, Bled, Slovenia. x, 22−23. (1).

5.2.

2011

Paaver, U., Laidmäe, I., Kozlova, J., Heinämäki, J., Kogermann, K., Veski, P. (2011). Novel method for preparation of amorphous composite nano-fibers of piroxicam. 44: 4th BBBB- Bled International Conference on Pharmaceutical Sciences, 29.09-01.10.2011, Bled, Slovenia. x, 150−151. (1).

5.2.

2011

Lust, A., Palo, M., Veski, P., Kogermann, K. (2011). EFFECT OF SOLID STATE TO THE DISSOLUTION BEHAVIOUR OF PIROXICAM IN ARTIFICIAL GASTRIC FLUID. 44: 4th BBBB- Bled International Conference on Pharmaceutical Sciences, Bled, Slovenia, 29.-01.10.2011. x, 101−102 . (1).

5.2.

2011

Paaver, U., Laidmäe, I., Kozlova, J., Veski, P., Heinämäki, J., Kogermann, K. (2011). A new method for preparation of amorphous composite nanofibers of piroxicam. 5th Annual PSSRC symposium, Helsinki, Finland, 26.09-27.09.2011.

5.2.

2011

Kogermann, K.; Veski, P.; Rantanen, J.; Naelapää, K. (2011). Preparation and Stabilization of Amorphous Piroxicam Using Co-milling Approach.

1.1.

2010

Naelapää, K; Veski, P; Kristensen, H.G; Rantanen, J; Bertelsen, P (2010). Building quality into a coating process. Pharmaceutical Development and Technology, 15 (1), 35−45.10.3109/10837450902882377.

1.1.

2010

Genina, N.; Räikkönen, H.; Ehlers, H.; Heinämäki, J.; Veski, P.; Yliruusi, J. (2010). Thin-coating as an alternative approach to improve flow properties of ibuprofen powder. International Journal of Pharmaceutics, 387, 65−70.

1.1.

2010

Genina, N.; Räikkönen, H.; Heinämäki, J.; Veski, P.; Yliruusi, J. (2010). Nano-coating of β-galactosidase onto the surface of lactose by using an ultrasound-assisted technique. AAPS PharmSciTech, 11 (2), 959−965.10.1208/s12249-010-9462-4.

1.3.

2010

Volmer, D.; Haavik, S.; Ekedahl, A.; Veski, P. (2010). Probleemsed retseptid, mille alusel ravimi väljastamine apteegist nõuab konsultatsiooni ravimi ordineerijaga – Eesti, Norra ja Rootsi võrdlusuuring. Eesti Arst, 5−12.

3.3.

2010

Hinrikus, T.; Jaamaste, M.; Kikas, E.; Kingisepp, P-H.; Laius, O.; Raal, A.; Sepp, S.; Toomvap, A-L.; Veski, P.; Volmer, D. (2010). Farmaatsiaterminoloogia: Euroopa farmakopöa ravimvormid, manustamisviisid, pakendid ja droogid. ATC süsteemid. Ravimiamet.

5.2.

2010

Paaver, U.; Mirza, S.; Veski, P.; Kogermann, K. (2010). The effect of hydrate water on piroxicam dissolution behaviour. In: .7th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; Valletta, Malta; 8-11.03.2010.

5.2.

2010

Kogermann, K.; Veski, P.; Rantanen, J.; Naelapää, K. (2010). The impact of thermal and mechanical stress on crystalline piroxicam forms. Application of X-ray powder diffractometry and Raman spectroscopy together with principal component analysis. PSSRC meeting in Cambridge, Great Britain, 19.-21.09.2010.

5.2.

2010

Naelapää, K.; Rantanen, J.; Veski, P.; Kogermann, K. (2010). Characterization of the thermal behaviour and physical stability of amorphous piroxicam. PSSRC meeting in Cambridge, Great Britain, 19.-21.09.2010.

5.2.

2010

Paaver, U.; Mirza, S.; Veski, P.; Rantanen, J.; Kogermann, K. (2010). Investigation of piroxicam dissolution behavior in the presence of excipient under various testing environments. 2010 PSWC /2010 AAPS Annual Meeting and Exposition, New Orleans, USA, 2010.

5.2.

2010

Naelapää, K.; Rantanen, J.; Veski, P.; Kogermann, K. (2010). Insight into the recrystallization behavior of amorphous piroxicam under various conditions. 2010 PSWC /2010 AAPS Annual Meeting and Exposition, New Orleans, USA, 2010.

5.2.

2010

Kogermann, K.; Veski, P.; Rantanen, J.; Naelapää, K. (2010). Preparation of amorphous piroxicam and monitoring of related solid state changes. 2010 PSWC /2010 AAPS Annual Meeting and Exposition, New Orleans, USA, 2010.

5.2.

2010

Volmer, D; Paaver, U; Veski, P (2010). Multidisciplinary approach to pharmacy master studies at the University of Tartu, Estonia. EAFP Annual Conference; Catania; 24-th-26-th of June 2010. University of Catania, Catania, 107−108.

1.1.

2009

Genina, N.; Räikkönen, H.; Heinämäki, J.; Antikainen, O.; Siiriä, S.; Veski, P.; Yliruusi, J. (2009). Effective modification of particle surface properties using ultrasonic water mist. AAPS PharmSciTech, 10 (1), 282−288.10.1208/s12249-009-9208-3.

3.4.

2009

Volmer, D.; Bell, J.S.; Veski, P. (2009). A European perspective on the future of the Pharmacy Profession. Oral presentation. New Progresses and Challenges in Pharmaceutical Sciences: 3-rd BBBB International Conference on Pharmaceutical Sciences, Turkey, Antalya; 26-28 October 2009. Ed. Hincal, A.A.; Celebi, N.; Yüksel, N. "Новое издательство", 340−347.

5.2.

2009

Volmer, D.; Teng, K.; Paaver, U.; Veski, P. (2009). Demand for continuing professional Education - perception of community pharmacists in Estonia. European Association of Faculties of Pharmacy 2009 Annual Conference: New Issues in Postgraduate/post-registration Pharmacy Education: European Association of Faculties of Pharmacy 2009 Annual Conference: New Issues in Postgraduate/post-registration Pharmacy Education; Oslo, Norway; June 18-20, 2009. Oslo, 54−54.

5.2.

2009

Genina, N.; Räikkönen, H.; Ehlers, H.; Heinämäki, J.; Veski, P.; Yliruusi, J. (2009). Finding out an appropriate surface treatment that would improve handling of poorly flowable powders. 2nd PharmSciFair, Nice, France 2009.

5.2.

2009

Genina, N.; Räikkönen, H.; Heinämäki, J.; Lauronen, E.; Veski, P.; Yliruusi, J. (2009). Effective modification of particle surfaces using ultrasonic water mist. Polymorfi, 1, 65, (2009), ISSN 1236-4002, 1458-5820 (pdf): Fysikaalisen farmasian XX vuosittainen symposium: Drug development of tomorrow – Opportunities and challenges, 28.-29.01.2009, Vihti, Finland.

1.1.

2008

Meos, A.; Paap, A.; Matto, V.; Veski, P. (2008). Comparative evaluation of quality of doxycycline formulations registered in Estonia to those registered in the Russian Federation. Drug Development Research, 69 (2), 58−68.10.1002/ddr.20228.

5.2.

2008

Genina, N.; Heinämäki, J.; Räikkönen, H.; Lauronen, E.; Veski, P.; Yliruusi, J. (2008). Application of superheated steam for rapid modification of drug particle surfaces. In: .19th Helsinki Drug Research Congress (HDR-2008); Helsinki, Finland;June 9-11, 2008.

5.2.

2008

Paaver, U.; Lehto, T.; Matto, V.; Veski, P. (2008). Effect of non-ionic surfactants on the in vitro release of poorly soluble drugs.

5.2.

2008

Naelapää, K; Veski, P; Kristensen, H.G; Rantanen, J; Bertelsen, P (2008). Design of Experiments – Critical Process Parameters. Workshop: Hands-on Implementation of PAT Systems in Production Processes, Ghent, Belgium, August 2008.

5.2.

2008

Genina, N.; Räikkönen, H.; Heinämäki, J.; Lauronen, E.; Veski, P.; Yliruusi, J. (2008). Effective modification of particle surfaces using ultrasonic water mist. AAPSAnnual Meeting and Exposition 2008, USA.

5.2.

2008

Genina, N.; Heinämäki, J.; Veski, P.; Yliruusi, J. (2008). Processing of powder particles by using a pulsatile application of pressurized hot steam. Polymorfi, 1, 24, (2008), ISSN 1236-4002, 1458-5820 (pdf): Fysikaalisen farmasian XIX vuosittainen symposium: Analytical methods in pharmacy – Industrial and novel applications, 24.01.2008, Vantaa, Finland.

5.2.

2008

Volmer, D.; Kask, T.; Veski, P. (2008). Estonian Pharmacy Students' Perceptions Towards Pharmacy Master Studies at University of Tartu. European Association of Faculties of Pharmacy 2008 Annual Conference "New issues in Pharmacy Education"; Lille; 12-14 June, 2008. 53.

1.1.

2007

Kogermann, K.; Aaltonen, J.; Strachan, C.J.; Pöllänen, K.; Veski, P.; Heinämäki, J.; Yliruusi, J.; Rantanen, J. (2007). Qualitative in situ analysis of multiple solid-state forms using spectroscopy and partial least squares discriminant modeling. Journal of Pharmaceutical Sciences, 96 (7), 1802−1820.10.1002/jps.20840.

1.1.

2007

Naelapää, K.; Veski, P.; Pedersen, J.G.; Anov, D.;Jørgensen, P.; Kristensen, H.G.; Bertelsen, P. (2007). . International Journal of Pharmaceutics, 332, 90−97.10.1016/j.ijpharm.2006.09.036.

1.2.

2007

Veski, P. (2007). Chronopharmaceutical Drug Delivery. Macedonian Pharmaceutical Bulletin, 53, 33−34.

1.2.

2007

Veski, P. (2007). Pharmacy Education in New EU Countries. Macedonian Pharmaceutical Bulletin, 53, 9−10.

5.1.

2007

Hinrikus, T.; Raal, A.; Veski, P. (2007). Pharmacy at the 375-year-old University of Tartu. European Journal of Pharmaceutical Sciences. Supplement: The 2nd BBBB Conference on Pharmaceutical Sciences; Tallinn-Tartu, Estonia; September 13-15, 2007. Ed. Urtti, A. Dorchester, UK: Elsevier Science BV, S1−S2.

5.1.

2007

Paaver, U.; Matto, V.; Veski, P. (2007). Effect of non-ionic surfactants on the dissolution of poorly soluble drugs. European Journal of Pharmaceutical Sciences, 32 (1), S34−S35.

5.1.

2007

Kreutzwald, P; Malinovskaja, K; Veski, P. (2007). Effect of diluents and disintegrants on the release of poorly soluble drugs from hard gelatin capsules. European Journal of Pharmaceutical Sciences, 32: 2nd BBBB Conference on Pharmaceutical Sciences, September 13-15, 2007, Tallinn-Tartu. Elsevier, S49−S50. (Issue 1, Suppl.).10.1016/j.ejps.2007.05.107.

5.1.

2007

Genina, N.; Heinämäki, J.; Veski, P.; Yliruusi, J. (2007). Processing of powder particles by using a pulsatile application of pressurized hot steam. European Journal of Pharmaceutical Sciences, 32: 2nd bbbb Conference on Pharmaceutical Sciences, September 13-15, 2007, Tallinn-Tartu. S47. (Suppl.; 1 ).

5.1.

2007

Naelapää, K.; Veski, P.; Kristensen, H.-G.; Bertelsen, P. (2007). Coating of potassium chloride with ethylcellulose aqueous dispersion - Effects of processing parameters on film formation and film properties. European Journal of Pharmaceutical Sciences, 32: 2nd BBBB Conference on Pharmaceutical Scoences; September 13-15, 2007; Tallinn-Tartu. Elsevier Science BV, S20. (Suppl.; 1).

5.1.

2007

Marvola, T.; Mahlamäki, S.; Kreutzwald, P.; Marvola, J.; Kanerva, H.; Ahonen, A.; Veski, P.; Marvola, M. (2007). Site-specific L-cysteine formulations for preservation of cancer in stomach and colon. European Journal of Pharmaceutical Sciences, 32: 2nd BBBB Conference on Pharmaceutical Sciences;Tallinn-Tartu; September 13-15, 2007. Elsevier Science BV, S6. (Issue 1, Suppl).

5.2.

2007

Paaver, U.; Matto, V.; Veski, P. (2007). Mitte-ioonsete pindaktiivsete ainete mõju halvastilahustuvate raviainete vabanemisele. Eesti Arst, 9, 670−671.

5.2.

2007

Paaver, U.; Matto, V.; Veski, P. (2007). Mitte-ioonsete pindaktiivsete ainete mõju halvastilahustuvate raviainete vabanemisele. Eesti Arst, 86 (9), 670−671.

5.2.

2007

Kreutzwald, P.; Veski, P.; Malinovskaja, K. (2007). Täiteainete ja disintegrantide mõju raskesti lahustuva raviaine in vitro vabanemisele kõvakapslitest. Eesti Arst: Arstiteaduskonna teaduskonverents; Tartu; 18. oktoober 2007. 689.

5.2.

2007

Volmer, D.; Veski, P. (2007). Implementation of clinical pharmacy into pharmacy curriculum at University of Tartu, Estonia. Abtracts Book ARFP 2007 Annual Conference: Trends in Pharmacy Education,Madrid, September 20-22, 2007. 94−95.

5.2.

2007

Paaver, U.; Veski, P. (2007). Role of the Estonian Academic Society of Pharmacy in improvement of pharmacy education in Estonia. Abstracts Book. EAFP 2007 Annual Conference "Trends in Pharmacy Education": Madrid, Spain; September 20-22, 2007. 78−79.

6.2.

2007

Hinrikus, T.; Veski, P.; Meos, A. (2007). Metoodiline juhend proviisoriõppe üliõpilaste uurimistööde vormistamiseks. Tartu: TÜ.

6.6.

2007

Veski, P.; Matto, V.; Raal, A.; Volmer, D.; Marvola, M.; Kristl, A.; Hincal, F. (2007). 2. BBBB Farmaatsiateaduste konverents Tartus 13-15.09.2007. Apteeker, 4 (20), 37−41.

2.2.

2006

Raal, Ain; Hinrikus, Toivo; Tankler, Hain; Veski, Pille (2006). Pharmacy at the University of Tartu. Tartu: Tartu Ülikool.

5.1.

2006

Kogermann, K.; Aaltonen, J.; Strachan, C.; Veski, P.; Heinämäki, J.; Yliruusi, J.; Rantanen, J. (2006). Monitoring of diverse hudrates using NIR and Raman spectroscopy - quantitative modellin of complex and simple systems. European Journal of Pharmaceutical Sciences, 28, 29.

5.2.

2006

Hinrikus, Toivo; Veski, Peep; Raal, Ain (2006). Quality assurance of the Estonian higher education. 2006 Annual Conference: Quality Assurance in Pharmacy Education 8-10 June 2006. Tallinn - Tartu: Tartu Ülikooli Kirjastus, 62−65.

5.2.

2006

Kogermann, K.; Aaltonen, J.; Strachan, C. J.; Veski, P; Heinämäki, J.; Yliruusi, J.; Rantanen, J. (2006). The utility of near infrared and Raman spectroscopy in investigating the phase transitions of hydrates during pharmaceutical processes. Dosis, 22: Joint Meeting of the Graduate School in Pharmaceutical Research, Kuopio, 17th -18th August 2006. Ed. Suomen Farmasialiitto. Forssan Kirjapaino Oy, 387. (2).

5.2.

2006

Kogermann, Karin; Aaltonen, Jaakko; Strachan, Clare Joanna; Veski, Peep; Heinämäki, Jyrki; Yliruusi, Jouko; Rantanen, Jukka (2006). Quantitative model construction for hydrate/anhydrate systems- benefits and possible pitfalls. POLYMORFI 2006: Fysikaalisen farmasian XVII vuosittainen symposium- vesi farmasiassa tutkimuksen ja tuotekehityksen näkökulmia, Turku, 26.01.2006. Ed. Mika Pulkkinen. Fysikaalisen farmasian yhdistys ry, 15−18.

5.2.

2006

Kogermann, K.; Aaltonen, J.; Strachan, C.J.; Pöllänen, K.; Veski, P.; Heinämäki, J.; Yliruusi, J.; Rantanen, J. (2006). Towards quantification of multiple solid state forms using spectroscopic techniques in pharmaceutical process environment. The American Association of Pharmaceutical Scientists Annual Meeting and Exposition 2006; San Antonio, Texas, USA; October/November 2006.

5.2.

2006

Kogermann, K.; Aaltonen, J.; Strachan, C. J.; Pöllänen, K.; Veski, P.; Heinämäki, J.; Yliruusi, J.; Rantanen, J. (2006). Development of quantitative methods with near infrared and Raman spectroscopy for Hydrate/Anhydrate Transitions in pharmaceutical process environments. The 8th International Workshop on Physical Characterization of Pharmaceutical Solids (IWPCPS-8); Rhodes/Greece; June 2006.

5.2.

2006

Kogermann, K.; Aaltonen, J.; Strachan, C. J.; Pöllänen, K.; Veski, P.; Heinämäki, J.; Yliruusi, J.; Rantanen, J. (2006). Monitoring of diverse hydrates using near infrared and Raman spectroscopy- quantitative modelling of complex and simple systems. Dosis: The 18th Helsinki Drug Research 2006, Helsinki/Finland, June 2006. Ed. Suomen Farmasialiitto. Forssan Kirjapaino Oy,.

5.2.

2006

Kogermann, K.; Aaltonen, J.; Strachan, C. J.; Heinämäki, J.; Veski, P.; Yliruusi, J.; Rantanen, J. (2006). Quantitative model construction for hydrate/anhydrate systems - benefits and possible pitfalls. 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology; Geneva, Switzerland; March 27-30, 2006.

6.2.

2006

Hinrikus, T.; Veski, P.; Meos, A. (2006). Uurimistööde vormistamine ja kaitsmine. Metoodiline juhend proviisoriõppe üliõpilastele. Tartu; Tartu Ülikool: -.

6.3.

2006

Hinrikus, T.; Kingisepp, P-H.; Plakso, M.; Raal, A.; Veski, P.; Volmer, D. (2006). Farmaatsiaterminoloogia VI. Droogid. Eesti Rohuteadlane, 4, 14−19.

6.3.

2006

Hinrikus, T.; Jaagola, M.; Kingisepp, P-H.; Plakso, M.; Raal, A.; Veski, P.; Volmer, D. (2006). Farmaatsiaterminoloogia V. Ravimvormid. Eesti Rohuteadlane, 1, 20−24.

6.6.

2006

Veski, Peep; Raal, Ain; Paaver, Urve (2006). Farmaatsiaharidusest, aga mitte ainult. Eesti Rohuteadlane, 5, 8−11.

1.2.

2005

Raal, Ain; Hinrikus, Toivo; Veski, Peep (2005). Una encuesta sobre las opiniones de los estudiantes de la Universidad Abierta en Estonia. Ars Pharmaceutica, 46 (3), 243−252.

1.2.

2005

Raal, A.; Hinrikus, T.; Veski, P. (2005). A survey of pharmacy students' opinions at the Open University in Estonia. Ars Pharmaceutica, 46 (3), 243−252.

3.4.

2005

Kreutzwald, P.; Paavo, M.; Veski, P. (2005). Using of the different increasing pH methods for dissolution test of modified release formulations. 1st BBBB Conference on Pharmaceutical Sciences (EUFEBS Conference). 166−169.

3.4.

2005

Marvola, T.; Suuronen, M.; Marvola, J.; Kanerva, H.; Ahonen, A.; Veski, P.; Kreutzwald, P.; Marvola, M. (2005). In vivo evaluation of enteric coated HPMC-capsules for the colonic drug delivery. 1st BBBB Conference on Pharmaceutical Sciences. Siofok, 183−185.

3.4.

2005

Veski, Peep; Hinrikus, Toivo; Raal, Ain (2005). Evaluation of pharmacy curriculum at the University of Tartu. Programme Book: 1st BBBB Conference on Pharmaceutical Sciences September 26-28, Siofok. Hungary. Siofok, 243−246.

3.4.

2005

Raal, Ain; Hinrikus, Toivo; Veski, Peep (2005). Distance learning of Pharmacy in Estonia: partnerships throughout diploma works. Programme Book: 1st BBBB Conference on Pharmaceutical Sciences September 26-28, Siofok. Hungary. Siofok, 209−213.

5.1.

2005

Kreutzwald, P.; Paavo, M.; Veski, P. (2005). Using of the different increasing pH methods for dissolution test of modified release formulations. European Journal of Pharmaceutical Sciences, 25, S137−S139.

5.2.

2005

Kogermann, K.; Aaltonen, J.; Strachan, C. J.; Heinämäki, J.; Veski, P.; Yliruusi, J.; Rantanen, J. (2005). Dehydration Behaviour of Structurally Diverse Hydrates. Dosis, 21: The Graduate School Joint Meeting in Pharmaceutical Sciences 2005, Helsinki/Finland, August 2005. Ed. Suomen Farmasialiitto. Forssan Kirjapaino Oy, 211. (3).

5.2.

2005

Aaltonen, J.; Evendi, K.; Heinämäki, J.; Veski, P.; Yliruusi, J.; Rantanen, J. (2005). Dehydration Studies on Structurally Diverse Hydrates. The 1st PharmSciFair 2005: Pharmaceutical Sciences Fair & Exhibition, Nice/France, June 2005. Nice/France, PO-298.

5.2.

2005

Aaltonen, J.; Kogermann, K.; Strachan, C. J.; Heinämäki, J.; Veski, P.; Yliruusi, J.; Rantanen, J. (2005). An Insight into Dehydration Phenomena. The 1st BBBB Conference on Pharmaceutical Sciences, Siόfok/Hungary, September 2005. Siόfok/Hungary, 106−108.

1.1.

2004

Nykanen, P.; Sten, T.; Jurjenson, H.; Veski, P.; Marvola, M. (2004). Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery. Pharmazie, 59 (4), 268−273.

1.3.

2004

Hinrikus, T.; Jaagola, M.; Kingisepp, P.-H.; Kokk, S.; Raal, A.; Veski, P.; Volmer, D.; Aasmäe, B. (2004). Farmaatsiaterminoloogia ja Euroopa farmakopöa. Eesti Arst, 83 (6), 414−432.

5.2.

2004

Hinrikus, T.; Raal, A.; Veski, P. (2004). Our first experience of the Open University in the Estonian pharmaceutical education. Annual conference of the European Association of Faculties of Pharmacy (EAFP): Pharmacy Education for the XXI Century. La Laguna, Tenerife, Spain, 10-13 March 2004. La Laguna, 46.

5.2.

2004

Raal, A.; Hinrikus, T.; Veski, P.; Tankler, H. (2004). Pharmacognosy in the curricula of pharmacy at the University of Tartu. Pharmacy Education for the XXI Century: Annual Conference of the European Association of Faculties of Pharmacy (EAFP); La Laguna, Spain; 10.-13.03.2004. La Laguna, Spain: Faculty of Pharmacy, University of La Laguna, 46.

1.1.

2003

Linna, A.; Ojala, S.; Jurjenson, H.; Veski, P.; Marvola, M. (2003). In vivo evaluation of matrix granules containing microcrystalline chitosan as a gel-forming excipient. International Journal of Pharmaceutics, 250 (1), 227−237.

1.1.

2003

Tuononen, T.; Jurjenson, H.; Veski, P.; Marvola, M. (2003). Evaluation of microcrystalline chitosans for gastro-retentive drug delivery. European Journal of Pharmaceutical Sciences, 19 (5), 345−353.

1.3.

2003

Veski, P. (2003). Ravimpreparaatide väljatöötamise tulevikusuunad. Eesti Arst, 9, 609−616.

6.2.

2003

Zharkovskaja, T.; Pokk, P.; Veski, P. (2003). Ravimite väljakirjutamine retseptis. Tartu Ülikooli Kirjastus.

6.2.

2003

Žarkovskaja, T.; Pokk, P.; Veski, P. (2003). Ravimite väljakirjutamine retseptis : käsiraamat üliõpilastele. Tartu: Tartu Ülikooli Kirjastus.

1.2.

2002

Raal, A.; Hinrikus, T.; Veski, P. (2002). The teaching of pharmacy at the University of Tartu trough the centuries. Pharmacy Education, 2 (2), 93−96.

1.3.

2002

Kreutzwald, Piret; Stokkeby, Piret; Oras, Iige; Veski, Peep (2002). Puhvrite pH ja koostise m©æju raviaine vabanemisele tahketest peroraalsetest ravimvormidest. Eesti Arst, 9, 568.

1.3.

2002

Hinrikus, T.; Jaagola, M.; Kingisepp, P.; Raal, A.; Veski, P.; Volmer, D. (2002). Farmaatsiaterminoloogia IV. Ravimvormide standardterminid. Eesti Rohuteadlane, 5, 16-17.

1.3.

2002

Hinrikus, T.; Jaagola, M.; Kingisepp, P.; Raal, A.; Veski, P.; Volmer, D. (2002). Farmaatsiaterminoloogia III. Pakendid. Eesti Rohuteadlane, 1, 19-21.

3.4.

2002

Volmer, Daisy; Tammaru, Tea-Mai; Raal, Ain; Arak, Elmar; Veski, Peep (2002). Estonian Retail Pharmacies on the way to the European Union. Pharmacy and pharmaceutical sciences World Congress, FIP 2002, Nice, France.

5.2.

2002

Hinrikus, T.; Raal, A.; Veski, P. (2002). Training of pharmacists at open university in Estonia. Integration in Pharmacy Education in Europe.: Integration in Pharmacy Education in Europe. Krakow, 25-27 April, 2002.. Krakow, 34−34.

5.2.

2002

Raal, A.; Hinrikus, T.; Veski, P. (2002). Motivation for obtaining the education of assistant of pharmacist at open university in Estonia. FIP 2002 Abstracts, Pharmacy and Pharmaceutical Science World Congress: 62nd Congress of FIP, Nice, France. Nice, France, 62−62.

5.2.

2002

Raal, A.; Hinrikus, T.; Veski, P.; Tankler, H. (2002). Farmaatsia instituut Tartu Ülikooli struktuuriüksusena läbi aegade. Eesti Arst, 9, 582.

5.2.

2002

Kreutzwald, P.; Stokkeby, P.; Oras, I.; Veski, P. (2002). Puhvrite pH ja koostise mõju raviaine vabanemisele tahketest peroraalsetest ravimvormidest. Eesti Arst, 81 (9), 568.

6.6.

2002

Hinrikus, T.; Jaagola, M.; Kingisepp, P.; Raal, A.; Veski, P.; Volmer, D. (2002). Euroopa farmkopöa terminoloogia. Eesti Loomaarstlik Ringvaade, 3 (Lisa), 1−14.

1.1.

2001

Nykanen, P.; Lempaa, S.; Aaltonen, ML.; Jurjenson, H.; Veski, P.; Marvola, M. (2001). Citric acid as excipient in multiple-unit enteric-coated tablets for targeting drugs on the colon. International Journal of Pharmaceutics, 229, 155−162.

1.1.

2001

Halsas, M.; Penttinen, T.; Veski, P.; Jurjenson, H.; Marvola, M. (2001). Time-controlled release pseudoephedrine tablets: bioavailability and in vitro/in vivo correlations. Pharmazie, 56 (9), 718−723.

1.3.

2001

Hinrikus, T.; Jaagola, M.; Kingisepp, P.; Raal, A.; Veski, P.; Volmer, D. (2001). Farmaatsiaterminoloogia. II Manustamisviisid. Eesti Rohuteadlane, 6, 21−23.

6.3.

2001

Veski, P. (2001). Farmaatsia Instituudi koht muutub. Eesti Rohuteadlane, 1, 4−9.

1.1.

2000

Lepist, EI.; Kusk, T.; Larsen, DH.; Andersen, D.; Frokjaer, S.; Taub, ME.; Veski, P.; Lennernas, H.; Friedrichsen, G.; Steffansen, B. (2000). Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporter. European Journal of Pharmaceutical Sciences, 11 (1), 43−50.

3.4.

2000

Säkkinen, M.; Seppälä, U.; Heinänen, P.; Veski, P.; Marvola, M. (2000). Stability and in vitro metabolism of dipeptide model prodrugs with affinity for the oligopeptide transporter. Proc. 3rd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology. 41−42.

5.2.

2000

Hinrikus, T.; Paavo, M.; Raal, A.; Veski, P. (2000). Pharmaceutical education in Estonia. FIP World Congress of Pharmacy 2000; Vienna, Austria; 27 August – 1 September 2000. Vienna, Pharmacy World Congress,.

1.1.

1999

Nykänen, P.; Krogars, K.; Säkkinen, M.; Heinämäki, J.; Jürjensson, H.; Veski, P.; Marvola, M. (1999). Organic acids as excipients in matrix granules for colon-specific drug delivery. International Journal of Pharmaceutics, 184 (2), 251−261.

1.1.

1999

Halsas, M.; Hietala, J.; Veski, P.; Jurjenson, H.; Marvola, M. (1999). Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations. International Journal of Pharmaceutics, 189 (2), 179−185.

1.1.

1999

Nykanen, P.; Jurjensson, H.; Veski, P.; Marvola, M. (1999). Organic acids as excipients in matrix granules for colon-specific drug delivery. International Journal of Pharmaceutics, 184 (2), 251−261.

1.2.

1999

Ansko, P.; Paavo, M.; Veski, P.; Kreutzwald, P. (1999). Using of the increasing pH methods for dissolution test of nifedipine modified release formulations. European Journal of Pharmaceutical Sciences, 8, 39.

1.3.

1999

Hinrikus, Toivo; Kingisepp, Peet-Henn; Raal, Ain; Rägo, Lembit; Veski, Peep; Volmer, Daisy; Jaagola, Malle; Plakso, Margit (1999). Farmaatsiaterminoloogia. Eesti Rohuteadlane, 4, 19−25.

5.2.

1999

Randla, P; Ansko, Piret; Paavo, Maaja; Veski, Peep (1999). Erisuguste suureneva pH meetodite kasutamine nifedipiini modifitseeritud vabanemisega preparaatide in vitro uuringutes. Arstiteaduskonna aastakonverents, 7. oktoober 1999. 103−104.

5.2.

1999

Lepist, E.-I.; Lennernäs, H.; Frokjaer, S.; Veski, P.; Steffansen, B. (1999). Affinity, stability and transport of D-Asp(Ofmoc)-Ala, a new model prodrug for oligopeptide transporter. Pharmaceutical Sciences,.

5.2.

1999

Halsas, M.; Veski, P.; Jürjenson, H.; Marvola, M. (1999). Effect of food on the bioavailability of ibuprofen from a press-caoted time-controlled release formulations. European Journal of Pharmaceutical Sciences. 41.

5.2.

1999

Randla, P.; Ansko, P.; Paavo, M.; Veski, P. (1999). Erisuguste suureneva pH meetodite kasutamine nifedipiini modifitseeritud vabanemisega preparaatide in vitro uuringutes. Arstiteaduskonna aastakonverents, 7. oktoober 1999 : teesid. 103−104.

5.2.

1999

Lepist, E.-I.; Kusk, T.; Larsen, D.; Veski, P.; Steffansen, B. (1999). hPepT1-afiinsete profarmakonide stabiilsus ja in vitro metabolism. Arstiteaduskonna aastakonverents 2007. Tartu. 18.10.2007. 63.

6.3.

1999

Jagomägi, A.; Veski, P. (1999). Tallinna Farmaatsiatehase 85 aastat Eesti ravimitootjana. Eesti Rohuteadlane, 1, 26−28.

1.1.

1998

Halsas, M.; Simelius, R.; Kiviniemi, A.; Veski, P.; Jurjenson, H.; Marvola, M. (1998). Effect of different combinations of hydroxypropylmethyl cellulose on bioavailability of ibuprofen from press-coated time-controlled tablets. STP Pharma Sciences, 8 (3), 155−161.

1.1.

1998

Halsas, M.; Ervasti, P.; Veski, P.; Jurjenson, H.; Marvola, M. (1998). Biopharmaceutical evaluation of time-controlled press-coated tablets containing polymers to adjust drug release. European Journal of Drug Metabolism and Pharmacokinetics, 23 (2), 190−196.

1.3.

1998

Raal, A.; Veski, P.; Jaagola, M. (1998). Euroopa farmakopöast II. Eesti Rohuteadlane, 2, 21−24.

1.3.

1998

Raal, A.; Veski, P.; Jaagola, M. (1998). Euroopa farmakopöa I. Eesti Rohuteadlane, 1, 31−34.

5.2.

1998

Halsas, M.; Hietala, J.; Veski, P.; Jürjenson, H.; Marvola, M. (1998). Morning vs evening dosing of ibuprofen in two different oral drug formulations. In: Proc. 2-nd World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (1196−1198).1998. Paris: Intern. Pharm. Abstr..

1.2.

1996

Petri, G.; Veszki, P.; Oroszlan, P.; Turiak, G. (1996). Cannabinoid content of foreign and domestic fibre hemp cultivated in Hungary. Acta Agronomica Hungarica, 44 (2), 133−140.

1.3.

1996

Ansko, P.; Veski, P.; Kreutzwald, P. (1996). Peroraalsete tahkete ravimpreparaatide kvaliteedi hindamine in vitro vabanemiskatsete tulemuste põhjal. Eesti Rohuteadlane, 3, 3−8.

1.3.

1996

Ansko, P.; Veski, P.; Kreutzwald, P. (1996). Peroraalselt manustatavate tahkete ravimpreparaatide in vivo käitumise hindamise võimalikkusest in vitro katsete tulemuste põhjal. Eesti Rohuteadlane, 2, 3−8.

1.2.

1995

Petri, G.; Nyiredy, Sz.; Veszki, P., Oroszlan, P.; Turiak, Gy. (1995). Kannabinoidok gazkromatografias vizsgalata tandem oszlopokon. Acta Pharmaceutica Hungarica, 63-67.

3.4.

1995

Veski, P.; Lepist, I.; Jürjenson, H.; Marvola, M. (1995). Prolongation of drug absorption from hard gelatin capsules using different viscosity grades of sodium alginates as diluents. Proc. 1st World Meeting APGI/APV. 929−930.

1.1.

1994

Sirkia, T.; Salonen, H.; Veski, P.; Jurjenson, H.; Marvola, M. (1994). Biopharmaceutical evaluation of new prolonged-release press-coated ibuprofen tablets containing sodium alginate to adjust drug-release. International Journal of Pharmaceutics, 107 (3), 179−187.

1.1.

1994

Veski, P.; Marvola, M.; Smal, J.; Heiskanen, I.; Jurjenson, H. (1994). Biopharmaceutical evaluation of pseudoephedrine hydrochloride capsules containing different grades of sodium alginate. International Journal of Pharmaceutics, 111 (2), 171−179.

2.3.

1994

Veski, P. (1994). Use of hard gelatin capsules and sodium alginates in peroral prolonged-release formulations. (Doktoritöö, Helsingin yliopisto.; Farmasian laitos.; Tartu Ülikool.; Farmaatsia instituut.; ). Helsinki,: Tartu Ülikooli Kirjastus.

1.1.

1993

Veski, P.; Marvola, M. (1993). Sodium alginates as diluents in hard gelatin capsules containing ibuprofen as a model-drug. Pharmazie, 48 (10), 757−760.

1.2.

1993

Veski, P.; Marvola, M.; Klinge, E.; Jürjenson, H. (1993). Bioavailability of ibuprofen from hard gelatin capsules containing sodium alginates. European Journal of Drug Metabolism and Pharmacokinetics, 158−163.10.1016/0378-5173(94)00133-2.

1.2.

1991

Veski, P.; Marvola, M. (1991). Design and use of equipment for simulation of plug formation in hard gelatin capsule filling machines. Acta pharmaceutica Fennica, 100, 19−25.

6.2.

1988

Veski, P.; Kirsch, L. (1988). Uuemad ekstraktsioonimeetodid : metoodiline juhend arstiteaduskonna farmaatsiaosakonna III...V kursuse üliõpilastele. Tartu,: Tartu Ülikooli Kirjastus.

1.1.

1981

Verzarpetri, G.; Veski, P.; Meszaros, S. (1981). Morphological comparison of local hemp varieties. Acta Agronomica Academiae Scientiarum Hungaricae, 30, 350−371.

3.4.

1980

Veszki, P.; Verzar-Petri, G.; Mezaros, S. (1980). Comparative phytochemical study on cannabinoid composition of the geographical varieties of the Cannabis sativa L. under the same conditions. II International Symposium on Spices and medicinal Plants. _EditorsAbbr Tétényi, P.; Máthé, A. Budapest, 95−103. (Acta Horticulturae; 96).

6.7.

1980

Veski, P. (1980). Kannabinoidok elöfordulása és megoszlása kenderfajtákban : kandidátusi értekezés. (Doktoritöö, Ungari TA). Budapest,: Ungari TA.

5.1.

1979

Verzarpetri, G.; Veszki, P.; Meszaros, S. (1979). Comparative phytochemical study of the cannabinoid composition of geographical varieties of cannabis-sativa l under the same conditions. Planta Medica, 36 (3), 258−259.

5.1.

1979

Lemberkovics, E.; Veszki, P.; Verzarpetri, G.; Trka, A. (1979). Contributions to the essential oil composition of the flowers and leaves of cannabis-sativa l. Planta Medica, 36 (3), 271−272.

Programm	Number	Nimi	Projekti algus	Projekti lõpp	Vastutav täitja	Asutus	Finantseerijapoolne rahastamine

SF	SF0182137s02	Ravimpreparaatide keemilised, füsikokeemilised ja biofarmatseutilised uuringud - kvaliteedi hindamine ja parandamine.	01.01.2002	31.12.2006	Peep Veski	Tartu Ülikool, Arstiteaduskond	127 056,34 EUR
MUU	MARFA11139	Ravimpreparaatide tuleviku testimismeetodid	01.10.2011	30.09.2014	Jyrki Tapio Heinämäki	Tartu Ülikool; Tartu Ülikool, Arstiteaduskond	26 657,00 EUR
ETF	ETF7980	Tahke raviaine füsikokeemilised omadused ja nende modifitseerimise võimalused	01.09.2010	31.08.2016	Karin Kogermann	Tartu Ülikool, Arstiteaduskond	53 544,46 EUR
SF	SF0180042s09	Tahkete raviainete füsikokeemilised omadused ja nende modifitseerimise võimalused	01.01.2009	31.12.2014	Karin Kogermann	Tartu Ülikool, Arstiteaduskond	305 007,90 EUR
AP	SF0180042s09AP	Väikesemahulise teaduse infrastruktuuri kaasajastamine teadusteema SF0180042s09 raames	01.01.2010	31.12.2011	Peep Veski	Tartu Ülikool, Arstiteaduskond	63 911,65 EUR
AP	SF0180042s09AP13	Väikesemahulise teaduse infrastruktuuri kaasajastamine teadusteema SF0180042s09 raames	01.01.2013	31.12.2013	Peep Veski	Tartu Ülikool, Arstiteaduskond	64 000,00 EUR

Eesti Teadusinfosüsteem

Peep Veski

Teenistuskäik

Kvalifikatsioon

Jooksvad projektid

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

Tööstusomand

Peep Veski

Career

Qualifications

Projects in progress

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

Otsi projekti

Eesti Teadusinfosüsteem

Peep Veski

Teenistuskäik

Kvalifikatsioon

Jooksvad projektid

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

Tööstusomand

Peep Veski

Career

Qualifications

Projects in progress

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

Otsi projekti

{{title}}

{{title}}

Otsi programmi